Infectious outcomes of a standardized subcutaneous immunoglobulin dose reduction strategy in primary immune deficiencies amid global shortage

Pedro Moral Moral, Pedro Moral Moral, Marta Dafne Cabanero-Navalon, Marta Dafne Cabanero-Navalon, Paula Teresa López-León, Paula Teresa López-León, Héctor Balastegui-Martín, Héctor Balastegui-Martín, Sandra Martínez Mercader, Sandra Martínez Mercader, Amparo Mir, Victor Garcia-Bustos, Victor Garcia-Bustos, Victor Garcia-Bustos

Open source

DOI: 10.3389/fimmu.2024.1527514
Published: 1
Container: Frontiers in Immunology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2024.1527514,
  title = {Infectious outcomes of a standardized subcutaneous immunoglobulin dose reduction strategy in primary immune deficiencies amid global shortage},
  author = {Pedro Moral Moral and Pedro Moral Moral and Marta Dafne Cabanero-Navalon and Marta Dafne Cabanero-Navalon and Paula Teresa López-León and Paula Teresa López-León and Héctor Balastegui-Martín and Héctor Balastegui-Martín and Sandra Martínez Mercader and Sandra Martínez Mercader and Amparo Mir and Victor Garcia-Bustos and Victor Garcia-Bustos and Victor Garcia-Bustos},
  year = {2025},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2024.1527514},
  url = {https://doi.org/10.3389/fimmu.2024.1527514}
}

RIS

TY  - JOUR
TI  - Infectious outcomes of a standardized subcutaneous immunoglobulin dose reduction strategy in primary immune deficiencies amid global shortage
AU  - Pedro Moral Moral
AU  - Pedro Moral Moral
AU  - Marta Dafne Cabanero-Navalon
AU  - Marta Dafne Cabanero-Navalon
AU  - Paula Teresa López-León
AU  - Paula Teresa López-León
AU  - Héctor Balastegui-Martín
AU  - Héctor Balastegui-Martín
AU  - Sandra Martínez Mercader
AU  - Sandra Martínez Mercader
AU  - Amparo Mir
AU  - Victor Garcia-Bustos
AU  - Victor Garcia-Bustos
AU  - Victor Garcia-Bustos
PY  - 2025
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2024.1527514
UR  - https://doi.org/10.3389/fimmu.2024.1527514
ER  -

APA

Moral, P. M., Moral, P. M., Cabanero-Navalon, M. D., Cabanero-Navalon, M. D., López-León, P. T., López-León, P. T., Balastegui-Martín, H., Balastegui-Martín, H., Mercader, S. M., Mercader, S. M., Mir, A., Garcia-Bustos, V., Garcia-Bustos, V., & Garcia-Bustos, V. (2025). Infectious outcomes of a standardized subcutaneous immunoglobulin dose reduction strategy in primary immune deficiencies amid global shortage. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2024.1527514

Source records

doaj · retrieved 2026-09-26T18:50:52.759Z